Abstract
Hb Plasencia is a thalassemic hemoglobin (Hb) mutation caused by a leucine to arginine replacement at residue 125 of the α2-globin chain (HBA2:c.377T>G). This variant was first described in the heterozygous state in association with a very mild α-thalassemic phenotype in three members of a Spanish family from Plasencia, Western Spain. Reviewing the molecular characterization of 308 Portuguese individual suspected of having α-thalassemia (α-thal) we found Hb Plasencia to be the second most frequent mutation after the –α3.7 deletion.
ACKNOWLEDGMENTS
This study was supported by Fórum Hematológico do Centro Hospitalar de Coimbra, Coimbra, Portugal.
Declaration of Interest:
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.